Biotech News
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
investors.beamtx.com2026-05-06 14:46 EST
CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat during the 2025 Jefferies London Healthcare Conference